Distinct signals control the hematopoiesis of lymphoid-related dendritic cells

Blood

Volumn 95, Issue 1, 2000, Pages 128-137

  Galy, Anne ^a   Christopherson, Indu ^b   Ferlazzo, Guido ^b   Liu, Guo ^b   Spits, Hergen ^b   Georgopoulos, Katia ^b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DENDRITIC CELL; GRANULOPOIESIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033966367     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.128     Document Type: Article

References (50)

1. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
2. Hart D. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 1997;90:3245-3287.
3. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186
4. Pulendran B, Smith J, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A. 1999;96:1036-1041.
5. Maldonado-Lopez R, De Smedt T, Michel P, et al. CD8a+ and CD8a- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med. 1999;189:587-592.
6. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
7. de Saint-Vis B, Fugier-Vivier I, Massacrier C, et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol. 1998;160:1666-1676.
8. Rescigno M, Martino M, Sutherland C, Gold M, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med. 1998;188:2175-2180.
9. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 1998;282:480-483.
10. Zhou LJ, Tedder TF. CD14+ monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A. 1996;93: 2588-2592.
11. Ferlazzo G, Klein J, Paliard X, Wei W, Galy A. Dendritic cells generated from CD34+ progenitor cells with flt3-ligand, c-kit-ligand, GM-CSF, IL-4 and TNF-a are functional antigen-presenting cells resembling mature monocyte-derived DC. J Immunother. In press.
12. Caux C, Dezutter-Dambuyant C, Schrmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258-261.
13. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol. 1992;52:274-281.
14. Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J Exp Med. 1996;184:695-706.
15. Ardavin C, Wu L, Li C-L, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 1993;362:761-763.
16. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 1995;3:459-473.
17. dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood. 1996;87:5196-5206.
18. + Pro-B cells can give rise to dendritic cells in vitro. J Immunol. 1998;161:5795-5799.
19. Saunders D, Lucas K, Ismaili J, et al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony stimulating factor. J Exp Med. 1996;184: 2185-2196.
20. Pulendran B, Lingappa J, Kennedy M, et al. Developmental pathways of dendritic cells in vivo. Distinct functions, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol. 1997;159:2222-2231.
21. Wu L, D'Amico A, Winkel K, Suter M, Lo D, Shortman K. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha + dendritic cells. Immunity. 1998;9:839-847.
22. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. Cell-autonomous defect in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity. 1997;7:483-492.
23. Georgopoulos K, Bigby M, Wang JH. et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994;79:143-156.
24. Wang JH, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996;5:537-549.
25. Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 1996;15:5358-5369.
26. Morgan B, Sun L, Avithal N, et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 1997;16:2004-2013.
27. Kelley CM, Ikeda T, Koipally J, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 1998;8:508-515.
28. Molnar A, Wu P, Largespada DA, et al. The Ikaros gene encodes a family of lymphocyte restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol. 1996; 156:585-592.
29. Galy A, Morel F, Hill B, Chen BP. Hematopoietic progenitor cells of lymphocytes and dendritic cells. J Immunother. 1998;21:132-141.
30. Hansen JD, Strassburger P, Du Pasquier L. Conservation of a master hematopoietic switch gene during vertebrate evolution: isolation and characterization of Ikaros from teleost and amphibian species. Eur J Immunol. 1997;27:3049-3058.
31. Kinsella T, Nolan G. Episomal vectors rapidly and stably produce high-liter recombinant retrovirus. Hum Gene Ther. 1996;7:1405-1413.
32. Heemskerk M, Blom B, Nolan G, et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med. 1997;186:1597-1602.
33. Ausubel F, Brent R, Kingston RE, et al. Current protocols in molecular biology. In: Janssen K, ed. New York, NY: John Wiley & Sons; 1995
34. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol. 1995;154: 3821-3835.
35. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991; 9:271-296.
36. Caux C, Massacrier C, Vanbervliet B, et al. CD34+ hematopoeitic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α: II functional analysis. Blood. 1997;90:1458-1470.
37. Ryan DH, Nuccie BL, Ritterman I, Liesveld J, Abboud C, Insel R. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood. 1997;89:929-940.
38. Santiago-Schwarz F, McCarthy M, Tucci J, Carsons S. Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CDH-dependent dendritic cell pathway. Blood. 1998;92:745-755.
39. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180:83-93.
40. Conneally E, Bardy P, Eaves CJ, et al. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood. 1996;87:456-464.
41. Bazil V, Strominger J. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol. 1991;147:1567-1574.
42. Small D, Levenstein M, Kim E, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci U S A. 1994;91: 459-463.
43. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the Flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995;3:147-161.
44. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996;184:1953-1962.
45. DiSanto J, Muller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A. 1995; 92:377-381.
46. + blood progenitors for anticancer therapy. Exp Hematol. 1995;23:1463-1471.
47. Rosenzwajg M, Camus S, Guigon M, Gluckman J. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells. Exp Hematol. 1998;26:63-72.
48. Varas A, Vicente A, Sacedon R, Zapata A. Interleukin-7 influences the development of thymic dendritic cells. Blood. 1998;92:93-100.
49. Vremec D, Lieschke G, Dunn A, Robb L, Metcalf D, Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol. 1997;27:40-44.
50. Wu L, Vremec D, Ardavin C, et al. Mouse thymus dendritic cells: kinetics of development and changes in surface markers during maturation. Eur J Immunol. 1995;25:418-425.